NDC 10122-165 – Elfabrio

Pegunigalsidase Alfa 5 mg/2.5mL · Injection, Solution, Concentrate · Intravenous

Human Prescription Drug

Product NDC10122-165

Product details

Brand name
Elfabrio
Generic name
Pegunigalsidase alfa
Labeler
Chiesi USA, Inc.
Dosage form
Injection, Solution, Concentrate
Route
Intravenous
Marketing category
BLA · BLA761161
Marketed since
May 23, 2023
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Elfabrio →

Package NDC codes (1)

Package NDCDescriptionSince
10122-165-021 VIAL, SINGLE-DOSE in 1 CARTON (10122-165-02) / 2.5 mL in 1 VIAL, SINGLE-DOSEJul 8, 2024

Other Elfabrio products